AIM ImmunoTech AIM
NYSE AIM
$0.17 +0.00 (+2.89%)
As of: Oct 21, 2026 · 1:23 PM EDT

AIM ImmunoTech (AIM) Receivables - Other (2018 - 2025)

Updated

AIM ImmunoTech (AIM) posted Receivables - Other of $19,000 for Q1 2025.

Analysis

AIM ImmunoTech (AIM) Receivables - Other (2018 - 2025) Analysis & Trends

At the end of FY2022, AIM ImmunoTech's Receivables - Other came in at $1.68 million, up 2.1% from FY2021.

  • Annual Receivables - Other has increased for three consecutive years, with a four-year compound annual growth rate of 18.2% (FY2018 to FY2022).
  • In prior years, AIM ImmunoTech's Receivables - Other was $1.64 million in FY2021 (+50.6%), $1.09 million in FY2020 (+40.5%), $776,000 in FY2019 (-9.7%) and $859,000 in FY2018.
  • The Q1 2025 figure stands as the highest quarterly Receivables - Other in data going back to Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.69 Bn 1,103.27 Bn 19.71 Bn
2 Johnson & Johnson 616.29 Bn 534.82 Bn 17.26 Bn
3 AbbVie 500.86 Bn 473.97 Bn 12.70 Bn
4 Merck 366.77 Bn 321.15 Bn 12.21 Bn
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn
7 Amgen 235.52 Bn 190.92 Bn 7.24 Bn
8 Gilead Sciences 190.49 Bn 164.69 Bn 6.22 Bn
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn
10 AIM ImmunoTech 2.93 Mn -18.37 Mn 21,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 19,000.00
Dec 31, 2022 1.68 Mn
Mar 31, 2022 1.64 Mn
Dec 31, 2021 1.64 Mn
Mar 31, 2021 1.09 Mn
Dec 31, 2020 1.09 Mn
Mar 31, 2020 776,000.00
Dec 31, 2019 776,000.00
Dec 31, 2018 859,000.00
API Access

AIM ImmunoTech Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=AIM&period=max&api_key=YOUR_API_KEY